Exome-wide rare variant analysis in familial essential tremor.

Autor: Diez-Fairen M; Fundació Docència i Recerca MútuaTerrassa, Movement Disorders Unit, Department of Neurology, University Hospital Mútua Terrassa, Terrassa, Barcelona, Spain., Houle G; Department of Human Genetics, McGill University, Montréal, Quebec, Canada; Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada., Ortega-Cubero S; Department of Neurology and Neurosurgery, Hospital Universitario de Burgos, Burgos, Spain., Bandres-Ciga S; Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA; Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), Granada, Spain., Alvarez I; Fundació Docència i Recerca MútuaTerrassa, Movement Disorders Unit, Department of Neurology, University Hospital Mútua Terrassa, Terrassa, Barcelona, Spain., Carcel M; Fundació Docència i Recerca MútuaTerrassa, Movement Disorders Unit, Department of Neurology, University Hospital Mútua Terrassa, Terrassa, Barcelona, Spain., Ibañez L; NeuroGenomics and Informatics, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA., Fernandez MV; NeuroGenomics and Informatics, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA., Budde JP; NeuroGenomics and Informatics, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA., Trotta JR; Centre Nacional d'Anàlisis Genòmic (CNAG-CRG), Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain & Universitat Pompeu Fabra (UPF), Barcelona, Spain., Tonda R; Centre Nacional d'Anàlisis Genòmic (CNAG-CRG), Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain & Universitat Pompeu Fabra (UPF), Barcelona, Spain., Chong JX; Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA., Bamshad MJ; Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA; Seattle Children's Hospital, Seattle, WA, 98105, USA; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Nickerson DA; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Aguilar M; Fundació Docència i Recerca MútuaTerrassa, Movement Disorders Unit, Department of Neurology, University Hospital Mútua Terrassa, Terrassa, Barcelona, Spain., Tartari JP; Fundació Docència i Recerca MútuaTerrassa, Movement Disorders Unit, Department of Neurology, University Hospital Mútua Terrassa, Terrassa, Barcelona, Spain., Gironell A; Movement Disorders Unit, Neurology Department, Hospital de Sant Pau and Sant Pau Biomedical Research Institute, Barcelona, 08026, Spain., García-Martín E; University Institute of Molecular Pathology Biomarkers, UNEx. ARADyAL Instituto de Salud Carlos III, Cáceres, Spain., Agundez JA; University Institute of Molecular Pathology Biomarkers, UNEx. ARADyAL Instituto de Salud Carlos III, Cáceres, Spain., Alonso-Navarro H; Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain., Jimenez-Jimenez FJ; Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain., Fernandez M; María de Maeztu Unit of Excellence, Institute of Neurosciences, University of Barcelona, MDM-2017-0729, Ministry of Science, Innovation and Universities, Spain; Parkinson's Disease & Movement Disorders Unit, Department of Neurology, Hospital Clínic, IDIBAPS, Barcelona, Spain., Valldeoriola F; Parkinson's Disease & Movement Disorders Unit, Department of Neurology, Hospital Clínic, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic de Barcelona, Barcelona, Spain., Marti MJ; Parkinson's Disease & Movement Disorders Unit, Department of Neurology, Hospital Clínic, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic de Barcelona, Barcelona, Spain., Tolosa E; Parkinson's Disease & Movement Disorders Unit, Department of Neurology, Hospital Clínic, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic de Barcelona, Barcelona, Spain., Coria F; Clinic for Nervous Disorders, Service of Neurology, Son Espases University Hospital, Palma de Mallorca, Spain., Pastor MA; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain., Vilariño-Güell C; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada., Rajput A; Saskatchewan Movement Disorders Program, University of Saskatchewan/Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada., Dion PA; Department of Human Genetics, McGill University, Montréal, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, H3A 2B4, Quebec, Canada., Cruchaga C; NeuroGenomics and Informatics, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA., Rouleau GA; Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, H3A 2B4, Quebec, Canada., Pastor P; Fundació Docència i Recerca MútuaTerrassa, Movement Disorders Unit, Department of Neurology, University Hospital Mútua Terrassa, Terrassa, Barcelona, Spain. Electronic address: pastorpau@gmail.com.

Publikováno v: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2021 Jan; Vol. 82, pp. 109-116. Date of Electronic Publication: 2020 Nov 24.

Treatment outcome and germline predictive factors of ropeginterferon alpha‐2b in myeloproliferative neoplasm patients.

Autor: Chen, Chih‐Cheng^1,2 (AUTHOR), Kuo, Ming‐Chung^2,3 (AUTHOR), Wang, Ying‐Hsuan^1,2 (AUTHOR), Pei, Sung‐Nan⁴ (AUTHOR), Huang, Ming‐Lih⁵ (AUTHOR), Chen, Chiu‐Chen³ (AUTHOR), Huang, Cih‐En^1,2 (AUTHOR), Chen, Yi‐Yang¹ (AUTHOR), Shih, Lee‐Yung^2,3 (AUTHOR) sly7012@adm.cgmh.org.tw

Publikováno v: Cancer Medicine. Apr2024, Vol. 13 Issue 7, p1-12. 12p.

The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease.

Autor: Li, Hangzhen¹ (AUTHOR), Zeng, Fancai¹ (AUTHOR), Huang, Cancan² (AUTHOR), Pu, Qiqi¹ (AUTHOR), Thomas, Elizabeth Rosalind³ (AUTHOR), Chen, Yan² (AUTHOR) chenyan0216@swmu.edu.cn, Li, Xiang¹ (AUTHOR) lix2009@126.com

Publikováno v: CNS Neuroscience & Therapeutics. Feb2024, Vol. 30 Issue 2, p1-14. 14p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives.

Autor: Chen, Min¹ (AUTHOR), Lan, Huanrong² (AUTHOR), Jin, Ketao³ (AUTHOR) jinketao2001@zju.edu.cn, Chen, Yun⁴ (AUTHOR) kuge19831010@163.com

Publikováno v: Drug Delivery. Dec2023, Vol. 30 Issue 1, p1-14. 14p.